Gyre Therapeutics (GYRE) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Gyre Therapeutics (GYRE) over the last 16 years, with Q3 2025 value amounting to 0.69.
- Gyre Therapeutics' Asset Utilization Ratio fell 1943.08% to 0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69, marking a year-over-year decrease of 1943.08%. This contributed to the annual value of 0.87 for FY2024, which is 2244.42% down from last year.
- Latest data reveals that Gyre Therapeutics reported Asset Utilization Ratio of 0.69 as of Q3 2025, which was down 1943.08% from 0.72 recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Asset Utilization Ratio ranged from a high of 16.8 in Q3 2023 and a low of 0.05 during Q2 2021
- Over the past 5 years, Gyre Therapeutics' median Asset Utilization Ratio value was 0.79 (recorded in 2025), while the average stood at 2.06.
- Per our database at Business Quant, Gyre Therapeutics' Asset Utilization Ratio surged by 2961075.23% in 2023 and then crashed by 9492.03% in 2024.
- Gyre Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.11 in 2021, then skyrocketed by 1515.85% to 1.77 in 2022, then rose by 1.5% to 1.79 in 2023, then plummeted by 52.95% to 0.84 in 2024, then dropped by 18.53% to 0.69 in 2025.
- Its last three reported values are 0.69 in Q3 2025, 0.72 for Q2 2025, and 0.79 during Q1 2025.